PRESCIENT THERAPEUTICS LIMITED (PTX)

Not featured in screeners

Not featured in screeners

Top insiders

Company data & Insiders

Download results Settings

James Campbell

1 purchase — total 5,000 AUD

Planned buy 11 Oct 2022

Value A$4,002,610.04 | Price 88.73 | Shares 99,991

Steven Lee Yatomi-Clarke

1 purchase — total 30,000 AUD

Planned buy 11 Oct 2022

Value A$210,082.47 | Price 57.15 | Shares 12,026

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-10-12	2022-10-11	PP Planned purchase	James Campbell Director	99,991 88.73 A$4,002,610	99,991	88.73	A$4,002,610
2022-10-12	2022-10-11	PP Planned purchase	Steven Lee Yatomi-Clarke Director	12,026 57.15 A$210,082	12,026	57.15	A$210,082

More insider trading research around PRESCIENT THERAPEUTICS LIMITED